Fulgent Genetics Inc (FLGT)
Healthcare
Diagnostics & Research
16.60 $
-18.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Fulgent Genetics Inc (FLGT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -24 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10 | 15 | 7.3 | 4.3 | -16 | 25 | -4.4 | -30 | 11 | -78 | 7.1 | -24 | -84 | |
| 6.4 | 6.5 | 6.7 | 6.2 | 5.9 | 6.2 | 5.9 | 6.1 | 6.0 | 6.1 | 6.0 | 6.0 | 24 | |
| 11 | 11 | 12 | 12 | 11 | 10 | 11 | 10 | 9.7 | 9.3 | 9.9 | 19 | 47 | |
| -11 | 10 | 4.9 | -2.6 | -26 | 16 | -9.8 | -39 | 2.4 | -72 | 17 | -17 | -69 | |
| 4.9 | 3.1 | 4.1 | 13 | 20 | 3.8 | 4.7 | 6.8 | 6.1 | 5.0 | 5.2 | 3.9 | 20 | |
| 20 | 24 | -47 | 7.3 | 9.0 | -27 | 28 | 53 | 19 | 11 | 11 | 51 | 92 | |
| -2.7 | -24 | -1.9 | -0.5 | -0.4 | -0.2 | -11 | -2.6 | -0.4 | -0.4 | -40 | -24 | -65 | |
| – | – | – | – | -0.1 | -0.1 | -0.6 | -0.1 | -0.1 | -0.1 | -0.6 | -0.1 | -0.8 | |
| -4.5 | -26 | -2.8 | -1.1 | -0.6 | -0.3 | -11 | -2.6 | -0.4 | -0.5 | -45 | -24 | -70 | |
| 26 | 13 | -43 | 10 | -6.9 | -2.9 | 12 | 21 | 30 | -67 | -27 | 3.0 | -61 | |
| 5.3 | 12 | 3.2 | -8.7 | -35 | 21 | -9.1 | -37 | 5.1 | -83 | 1.9 | -28 | -104 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.